Zach Sweeney
Keine laufenden Positionen mehr
Profil
Derzeit bekleidet Zach Sweeney die Position des Chief Scientific Officer von Denali Therapeutics, Inc. Dr. Sweeney erwarb einen Bachelor-Abschluss an der Stanford University.
Ehemalige bekannte Positionen von Zach Sweeney
| Unternehmen | Position | Ende |
|---|---|---|
| DENALI THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Zach Sweeney
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
